The CDC’s advisory panel voted to change the recommendation for the hepatitis B vaccine, delaying the first dose to 2 months for children born to virus-negative mothers. Medical experts oppose the change, citing safety and effectiveness of the vaccine. The decision, influenced by ACIP members, faces criticism from senators and may impact insurance coverage. CDC Director O’Neill supports the discussion but faces backlash against the potential change.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
